Published in Clin Endocrinol (Oxf) on May 18, 2017
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med (1994) 8.39
Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab (2001) 4.73
The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab (2011) 1.74
Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab (2010) 1.65
Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131) Ann Surg (1994) 1.21
Papillary thyroid cancer: time course of recurrences during postsurgery surveillance. J Clin Endocrinol Metab (2013) 1.16
Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. Laryngoscope (2008) 1.08
Effect of reoperation on outcomes in papillary thyroid cancer. Surgery (2013) 1.04
Reoperative experience with papillary thyroid cancer. World J Surg (2014) 1.00
Update in utility of secondary node dissection for papillary thyroid cancer. J Clin Endocrinol Metab (2012) 0.89
Management of recurrent and persistent metastatic lymph nodes in well-differentiated thyroid cancer: a multifactorial decision-making guide for the thyroid cancer care collaborative. Head Neck (2014) 0.88
Prognosis of patients with papillary thyroid carcinoma showing postoperative recurrence to the central neck. World J Surg (2011) 0.86
Efficacy and safety of central compartment neck dissection for recurrent thyroid carcinoma. Arch Otolaryngol Head Neck Surg (2012) 0.82
Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma. Thyroid (2011) 0.79
Iodine-131 radio-guided surgery in differentiated thyroid cancer: outcome on 31 patients and review of the literature. Biomed Pharmacother (2007) 0.79
Impact of initial surgical treatment on survival of patients with differentiated thyroid cancer: experience of an endocrine surgery center in an iodine-deficient region. World J Surg (2000) 0.79
Role of RAI in the management of incidental N1a disease in papillary thyroid cancer. Clin Endocrinol (Oxf) (2015) 0.78